NSE ScannerComparison · NSE · data 2026-10-31
Laurus Labs Ltd. vs Sun Pharmaceutical Industries Limited
In plain words
Size: Sun Pharmaceutical Industries Limited is about 3.3 times the market value of Laurus Labs Ltd..
Valuation (P/E): Laurus Labs Ltd. 97.1 vs Sun Pharmaceutical Industries Limited 38.9.
Return on equity: Laurus Labs Ltd. 18.2% vs Sun Pharmaceutical Industries Limited 14.7%.
Profit growth over 3 years: Sun Pharmaceutical Industries Limited 10.6% a year vs Laurus Labs Ltd. 4% a year.
Debt to equity: Laurus Labs Ltd. 0.48 vs Sun Pharmaceutical Industries Limited 0.06.
Differences in the numbers, not a recommendation of either stock.
Side by side
| LAURUSLABS | SUNPHARMA | |
|---|---|---|
| Price | ₹2,405.5 | ₹1,777.7 |
| Market cap | ₹1,29,243 cr | ₹4,26,652 cr |
| P/E | 97.1 | 38.9 |
| P/B | 21.5 | 4.8 |
| ROE | 18.2% | 14.7% |
| ROCE | 20.5% | 17.7% |
| Debt / equity | 0.48 | 0.06 |
| Operating margin | 24.1% | 23.2% |
| Dividend yield | 0.08% | 0.90% |
| Sales growth, 3 years (yearly) | 4.1% | 9.9% |
| Profit growth, 3 years (yearly) | 4.0% | 10.6% |
| 1-year return | 149.8% | 3.6% |
| Revenue, last 12 months | ₹7,823 cr | ₹61,631 cr |
| Net profit, last 12 months | ₹1,340 cr | ₹10,966 cr |
| Latest quarter | Jun 2024 | Dec 2024 |
| Quarter net profit | ₹13 cr | ₹2,903 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 27.49% | 54.48% |
| Health check | Average (6/10) | Average (6.1/10) |
Common questions
Which has a higher P/E, Laurus Labs Ltd. or Sun Pharmaceutical Industries Limited?
Laurus Labs Ltd. trades at the higher P/E (97.1 against 38.9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Laurus Labs Ltd. (18.2% against 14.7%).
Which carries more debt?
Laurus Labs Ltd. has the higher debt-to-equity ratio (0.48 against 0.06).